OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar‐Bravo, Sílvia Ariño, Delia Blaya, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 728-740
Open Access | Times Cited: 17
Beatriz Aguilar‐Bravo, Sílvia Ariño, Delia Blaya, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 728-740
Open Access | Times Cited: 17
Showing 17 citing articles:
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 117
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 117
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
Hui Gao, Yanchao Jiang, Zeng Ge, et al.
eGastroenterology (2024) Vol. 2, Iss. 4, pp. e100104-e100104
Open Access | Times Cited: 11
Hui Gao, Yanchao Jiang, Zeng Ge, et al.
eGastroenterology (2024) Vol. 2, Iss. 4, pp. e100104-e100104
Open Access | Times Cited: 11
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 10
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 10
Pathogenesis of Alcohol-Associated Liver Disease
Pranoti Mandrekar, Abhishek Mandal
Clinics in Liver Disease (2024) Vol. 28, Iss. 4, pp. 647-661
Closed Access | Times Cited: 6
Pranoti Mandrekar, Abhishek Mandal
Clinics in Liver Disease (2024) Vol. 28, Iss. 4, pp. 647-661
Closed Access | Times Cited: 6
Ductular Reactions in Liver Injury, Regeneration, and Disease Progression—An Overview
Nirmala Mavila, Mallikarjuna Siraganahalli Eshwaraiah, J. Kennedy
Cells (2024) Vol. 13, Iss. 7, pp. 579-579
Open Access | Times Cited: 4
Nirmala Mavila, Mallikarjuna Siraganahalli Eshwaraiah, J. Kennedy
Cells (2024) Vol. 13, Iss. 7, pp. 579-579
Open Access | Times Cited: 4
Stromal Cell Derived Factor‐1 Promotes Hepatic Insulin Resistance via Inhibiting Hepatocyte Lipophagy
Chunfeng Lu, Yuting Zhang, Cuilian Sun, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Chunfeng Lu, Yuting Zhang, Cuilian Sun, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice
Lingjie Meng, Huijing Lv, Anli Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lingjie Meng, Huijing Lv, Anli Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cholestasis in alcohol-associated liver disease
Shengmin Yan, Xiao‐Ming Yin
American Journal Of Pathology (2025)
Open Access
Shengmin Yan, Xiao‐Ming Yin
American Journal Of Pathology (2025)
Open Access
Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights
Corinn N. Marakovits, Heather Francis
AJP Cell Physiology (2023) Vol. 326, Iss. 3, pp. C698-C706
Closed Access | Times Cited: 9
Corinn N. Marakovits, Heather Francis
AJP Cell Physiology (2023) Vol. 326, Iss. 3, pp. C698-C706
Closed Access | Times Cited: 9
Alcohol-associated liver disease: Emerging therapeutic strategies
Benjamin H. Mullish, Mark Thursz
Hepatology (2024) Vol. 80, Iss. 6, pp. 1372-1389
Closed Access | Times Cited: 3
Benjamin H. Mullish, Mark Thursz
Hepatology (2024) Vol. 80, Iss. 6, pp. 1372-1389
Closed Access | Times Cited: 3
Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD
Jing Bai, Lun Zhu, Wanqi Mi, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 6
Jing Bai, Lun Zhu, Wanqi Mi, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 6
Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks
Guilherme Ribeiro Romualdo, Renato Heidor, Gabriel Bacil Prata, et al.
Life Sciences (2023) Vol. 330, pp. 121994-121994
Closed Access | Times Cited: 4
Guilherme Ribeiro Romualdo, Renato Heidor, Gabriel Bacil Prata, et al.
Life Sciences (2023) Vol. 330, pp. 121994-121994
Closed Access | Times Cited: 4
Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease
Una Rastovic, Sergio Francesco Bozzano, Antonio Riva, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 150-150
Open Access | Times Cited: 4
Una Rastovic, Sergio Francesco Bozzano, Antonio Riva, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 150-150
Open Access | Times Cited: 4
Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities
Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, et al.
Gastroenterology (2024)
Closed Access | Times Cited: 1
Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, et al.
Gastroenterology (2024)
Closed Access | Times Cited: 1
Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation
Chenxi Yang, Ye Yang, Xiuya Hu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1924-1936
Closed Access
Chenxi Yang, Ye Yang, Xiuya Hu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1924-1936
Closed Access
YAP mediates HIV-related liver fibrosis
Volney A. Spalding, Brian A. Fellenstein, James Ahodantin, et al.
JHEP Reports (2024) Vol. 6, Iss. 11, pp. 101163-101163
Open Access
Volney A. Spalding, Brian A. Fellenstein, James Ahodantin, et al.
JHEP Reports (2024) Vol. 6, Iss. 11, pp. 101163-101163
Open Access
Immunology and treatments of fatty liver disease
Sainan Tang, Shanshan Wu, Wenzhe Zhang, et al.
Archives of Toxicology (2024) Vol. 99, Iss. 1, pp. 127-152
Closed Access
Sainan Tang, Shanshan Wu, Wenzhe Zhang, et al.
Archives of Toxicology (2024) Vol. 99, Iss. 1, pp. 127-152
Closed Access
